West Virginia 2022 Regular Session

West Virginia House Bill HB4324

Introduced
1/21/22  
Refer
1/21/22  
Engrossed
1/31/22  
Refer
2/1/22  
Refer
2/1/22  
Report Pass
3/2/22  
Enrolled
3/8/22  
Passed
3/12/22  

Caption

To update collaborative pharmacy practice agreements

Impact

If passed, HB4324 would lead to legislative updates that allow pharmacists to engage in more comprehensive drug therapy management. This encompasses conducting patient evaluations, modifying drug therapy, and ensuring effective communication with physicians about patient care. The emphasis on documentation and regular reporting back to physicians is intended to enhance patient outcomes and optimize medication therapy, thereby aligning pharmacy practices more closely with modern healthcare needs.

Summary

House Bill 4324 aims to update and enhance collaborative pharmacy practice agreements in West Virginia. The bill amends existing sections of the state code that govern the roles and responsibilities of pharmacists in collaborative practices with physicians. One of the significant aspects of this bill is the introduction of clearer definitions and requirements for collaborative pharmacy practice agreements, which delineate the scope of work pharmacists can undertake in patient care. It essentially facilitates a cooperative relationship between pharmacists and physicians to manage patient drug therapy more effectively.

Sentiment

The sentiment around HB4324 appears to be largely positive, particularly among healthcare professionals who advocate for expanded pharmacist roles in patient care. Supporters argue that this bill will not only enhance the role of pharmacists but also improve health outcomes by fostering better collaboration within healthcare teams. However, there may also be concerns from some stakeholders regarding the potential for overreach into areas traditionally reserved for doctors, indicating a need for careful integration of these practices.

Contention

While support for HB4324 exists, contention may arise over how far pharmacists should go in managing drug therapies, particularly when it comes to making clinical decisions without direct physician involvement. There is also concern regarding the management of controlled substances, as the bill explicitly prohibits collaborative agreements from covering these areas. This limitation may raise discussions on the appropriateness of pharmacist involvement in various patient care scenarios and the potential implications for patient safety.

Companion Bills

No companion bills found.

Previously Filed As

WV HB2490

Pharmacists; providers; collaborative practice agreements

WV S357

Pharmacists/Collaborative Practice

WV S597

Pharmacists/Collaborative Practice

WV HB2582

Pharmacists; collaborative practice agreements

WV HB1582

Pharmacists; collaborative agreements, drug therapy.

WV H5852

Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”

WV SB228

Practice of pharmacy; authorizing pharmacist to enter into certain collaborative practice agreements. Effective date.

WV SB228

Practice of pharmacy; authorizing pharmacist to enter into certain collaborative practice agreements. Effective date.

WV SB232

Practice of pharmacy; authorizing pharmacist to perform certain services under collaborative practice agreement. Effective date.

WV HB1300

Ivermectin; authorize pharmacists to provide to adults pursuant to collaborative pharmacy practice agreement.

Similar Bills

UT HB0301

Medication Dispenser Amendments

MT HB794

Revise pharmacy laws

UT SB0312

Pharmacy Practice Amendments

KS HB2366

Expanding the scope of practice of naturopathic doctors, specifying continuing education requirements, increasing the required amount of professional liability insurance and modifying certain provisions relating to the licensure and regulations of naturopathic doctors.

KS SB121

Broadening the scope of practice of naturopathic doctors and changing certain provisions pertaining to the licensure and regulation of naturopathic doctors.

UT SB0207

Pharmacy Practice Act Amendments

NM HB93

Pharmacy Act & Board Of Pharmacy Changes

KS SB496

Expanding the scope of practice of naturopathic doctors, specifying continuing education requirements, increasing the required amount of professional liability insurance and modifying certain provisions relating to the licensure and regulations of naturopathic doctors.